Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
| NCT ID | Title | Phase | Status | Enrollment | Velocity | Design | Start | Completion | Last Updated | Sites | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NCT01011608 | Effect of a Medical Food Supplement in Hospitalized Patients Recovering From Surgery | PHASE3 | COMPLETED | 127 | — | — | Nov 1, 2009 | Sep 1, 2010 | Apr 4, 2011 | 11 | Russia |
| Arm | Type | Description |
|---|---|---|
| Medical Food Supplement | EXPERIMENTAL | Medical food supplement to be given in divided portions in morning, afternoon and evening |
| standard hospital food | ACTIVE_COMPARATOR | standard hospital diet |
| Name | Type | Description |
|---|---|---|
| Medical Food Supplement | OTHER | Medical Food Supplement to be given in divided portions in morning, afternoon and evening |
| standard hospital food | OTHER | standard hospital diet ad. lib. |
Inclusion Criteria: * Subject is \> 45 years of age. * Subject is a male or a non-pregnant, non-lactating female, at least 6 weeks postpartum prior to screening visit. * Subject plans to undergo hip fracture surgery. * Subject has anticipated length of hospital stay of at least 4 weeks. Subject is ...
| Company | Ticker | Trials | Lead Phase | Drugs |
|---|---|---|---|---|
| Zimmer Biomet Holdings, Inc. | ZBH | 23 | NA | Undisclosed |
| Stryker Corporation | SYK | 4 | — | Undisclosed |
| Johnson & Johnson | JNJ | 1 | NA | Undisclosed |
| Orthofix Medical, Inc. | OFIX | 1 | — | Undisclosed |
| Cooper Companies, Inc. | COO | 1 | — | Undisclosed |